On friday, drugmaker lykos therapeutics received word from the food and. The fda declined to approve mdma as a treatment for ptsd, requesting further clinical trials to address safety concerns and data integrity Despite promising results from previous studies, the fda's advisory panel cited issues with trial design and misconduct. Federal health officials have declined to approve the psychedelic drug mdma as a therapy for ptsd Drugmaker lykos therapeutics announced the fda's decision on friday. Image by wirestock on freepik recently, the u.s
Fda’s scientific advisors overwhelmingly concluded that the effectiveness of mdma in treating ptsd has not been proven and that its risks outweigh its benefits
WATCH
